Can molecular biomarkers do for a North Carolina town what silicon chips did for California’s Silicon Valley? At least one city in the Tar Heel State hopes that it can develop into a major hub for research, development, and the commercialization of molecular science and next-generation gene sequencing.
The unlikely contender pursuing this goal is the city of Kannapolis. With a population of 43,000 and located about 25 miles northwest of Charlotte, the city fathers of Kannopolis appear to be positioning the community as an up-and-coming global center for biobanking.
Long-Term Study of Population’s Diseases Uses Genetics, Other Data.
One impetus for this goal is the $35-million MURDOCK study. This acronym stands for “Measurement to Understand the Reclassification of Disease of Cabarrus/Kannapolis.”
Thanks,
Kruti